National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
- 1 February 2017
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 24 (4) , 262-267
Abstract
Summary: Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we describe the process of development of the Egyptian model and future strategies for sustainability. Although the magnitude of the HCV problem was known for many years, the HCV MOC only came into being in 2006 with the establishment of the National Committee for Control of Viral Hepatitis (NCCVH) to set up and implement a national control strategy for the disease and other causes of viral hepatitis. The strategy outlines best practices for patient care delivery by applying a set of service principles through identified clinical streams and patient flow continuums. The Egyptian national viral hepatitis treatment programme is considered one of the most successful and effective public health programmes. To date, more than one million patients were evaluated and more than 850 000 received treatment under the umbrella of the programme since 2006. The NCCVH has been successful in establishing a strong infrastructure for controlling viral hepatitis in Egypt. It established a nationwide network of digitally connected viral hepatitis‐specialized treatment centres covering the country map to enhance treatment access. Practice guidelines suiting local circumstances were issued and regularly updated and are applied in all affiliated centres. This review illustrates the model and the successful Egyptian experience. It sets an exemplar for states, organizations and policy‐makers setting up programmes for care and management of people with hepatitis C.Keywords
This publication has 13 references indexed in Scilit:
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatmentLiver International, 2016
- The current and future disease burden of chronic hepatitis C virus infection in EgyptArab Journal of Gastroenterology, 2014
- The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian StudyHepatitis Monthly, 2013
- HCV iatrogenic and intrafamilial transmission in Greater Cairo, EgyptGut, 2010
- Evidence of intense ongoing endemic transmission of hepatitis C virus in EgyptProceedings of the National Academy of Sciences, 2010
- Injection Drug Use Is a Risk Factor for HCV Infection in Urban EgyptPLOS ONE, 2009
- Changing pattern of hepatitis C virus spread in rural areas of EgyptJournal of Hepatology, 2005
- Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence dataInternational Journal of Epidemiology, 2004
- Global Burden of Disease (GBD) for Hepatitis CThe Journal of Clinical Pharmacology, 2004
- The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptThe Lancet, 2000